ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Siberian scientists say stem cells can treat varicose veins – Russia Beyond the Headlines

Continue reading

2017-06-29 Michael Zand NEWS

Eiger Sells Cardiovascular Gene Therapy to Theragene in $18.1M Deal – Pharmaceutical Processing


Russia Beyond the Headlines

Siberian scientists say stem cells can treat varicose veins
Russia Beyond the Headlines
“Quite a lot of pathologies regarding veins still remain unstudied,” said Igor Mayborodin, a doctor of medical sciences at the stem cell laboratory at ICBFM. “We’ve looked into blood flow restoration in situations when there are blood clots. Now we’re …

Continue reading

2017-06-29 Michael Zand NEWS

Servier Recruits Viral Vector Expert to Step Up its CAR-T Technology – Labiotech.eu (blog)

Labiotech.eu (blog)Servier Recruits Viral Vector Expert to Step Up its CAR-T TechnologyLabiotech.eu (blog)Transgene will help Servier develop new methods based on viral vectors to improve the precision of genetic modifications and the production of … Continue reading

2017-06-29 Michael Zand NEWS

Servier Recruits Viral Vector Expert to Step Up its CAR-T Technology – Labiotech.eu (blog)

Labiotech.eu (blog)Servier Recruits Viral Vector Expert to Step Up its CAR-T TechnologyLabiotech.eu (blog)Transgene will help Servier develop new methods based on viral vectors to improve the precision of genetic modifications and the production of … Continue reading

2017-06-29 Michael Zand NEWS

Can CRISPR Conquer Huntington’s? – PLoS Blogs (blog)


Pharmaceutical Processing

Eiger Sells Cardiovascular Gene Therapy to Theragene in $18.1M Deal
Pharmaceutical Processing
Eiger BioPharmaceuticals announced an agreement to sell to Theragene Pharmaceuticals, Inc., a private biotechnology company, a non-strategic asset, Mydicar® (rAAV1-SERCA2a). Financial terms of the agreement include a total upfront of $3.1 million in …
Eiger sells gene therapy candidate Mydicar to Theragene for $3.1M in cash and stockSeeking Alpha

all 6 news articles »

Continue reading

2017-06-29 Michael Zand NEWS

Can CRISPR Conquer Huntington’s? | DNA Science Blog – PLoS Blogs (blog)

Can CRISPR Conquer Huntington’s?
PLoS Blogs (blog)
I set a high bar for writing about mouse studies. I don’t include them in my textbooks or news articles, and only rarely blog about them. But when experiments in mice shine a glimmer of hope on a horrific illness with a long history of failed …

Continue reading

2017-06-29 Michael Zand NEWS

Servier embarks on another collaboration in immuno-oncology – The Pharma Letter (registration)


PLoS Blogs (blog)

Can CRISPR Conquer Huntington’s? | DNA Science Blog
PLoS Blogs (blog)
I set a high bar for writing about mouse studies. I don’t include them in my textbooks or news articles, and only rarely blog about them. But when experiments in …
Gene Editing Reverses Huntington’s in Mouse StudyBioscience Technology

all 2 news articles »

Continue reading

2017-06-29 Michael Zand NEWS

Abeona Therapeutics Receives FDA Orphan Drug Designation for ABO-201 Juvenile Batten Disease Gene Therapy … – Nasdaq


The Pharma Letter (registration)

Servier embarks on another collaboration in immuno-oncology
The Pharma Letter (registration)
France’s Servier Laboratories and Transgene have started working together to try to develop simpler, faster and more effective ways of engineering CAR-T cell …
Servier and Transgene Have Become Partners to Apply Viral Vectorization Technology to the Engineering of Allogenic …PharmiWeb.com (press release)

all 6 news articles »

Continue reading

2017-06-29 Michael Zand NEWS
  • 1
  • …
  • 1,562
  • 1,563
  • 1,564
  • 1,565
  • 1,566
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Weekly Register

Abeona Therapeutics Receives FDA Orphan Drug Designation for ABO-201 Juvenile Batten Disease Gene Therapy …
Nasdaq
NEW YORK and CLEVELAND, June 29, 2017 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare diseases, announced …
Is Abeona Therapeutics Incorporated (NASDAQ:ABEO)’s Fuel Running Low? Reports Show More SellersWeekly Register

all 17 news articles »